I advise and lead finance for life sciences and medtech companies, from early-stage operations to public-market deals.
At Tialma I help companies with investor relations, finance operations and M&A, from deal origination to closing.
I've delivered value in transactions from $10 million to $1 billion, raising capital and taking companies public.
One piece argues an operating CFO is a founder's “another adult in the room.”
With Joel Palathinkal I walked students through M&A modeling for VC-backed companies, with Excel demos.
I also helped manage the buildout of a commercial scale cell and biologics manufacturing facility in Puerto Rico.
DIH is a Swiss-Chinese medical equipment maker with $80m in sales and 400 employees globally.
As interim CFO of this oncology immunotherapy company, I also raised $10.7 million in financing.
I made $500m+ in principal and control investments across dozens of deals, after starting as a banker at SG Cowen.
I advise and lead finance for life sciences and medtech companies, from early-stage operations to public-market deals.
At Tialma I help companies with investor relations, finance operations and M&A, from deal origination to closing.
I've delivered value in transactions from $10 million to $1 billion, raising capital and taking companies public.
One piece argues an operating CFO is a founder's “another adult in the room.”
With Joel Palathinkal I walked students through M&A modeling for VC-backed companies, with Excel demos.
I also helped manage the buildout of a commercial scale cell and biologics manufacturing facility in Puerto Rico.
DIH is a Swiss-Chinese medical equipment maker with $80m in sales and 400 employees globally.
As interim CFO of this oncology immunotherapy company, I also raised $10.7 million in financing.
I made $500m+ in principal and control investments across dozens of deals, after starting as a banker at SG Cowen.
By using this service, you agree to the Terms of Service and Privacy Policy.